Literature DB >> 1828756

Antibiotic resistance of Clostridium difficile isolates.

A Dworczyński1, B Sokół, F Meisel-Mikołajczyk.   

Abstract

The activity of metronidazole, vancomycin, clindamycin and teicoplanin against Clostridium difficile strains isolated from various origins in Poland was investigated. MIC was determined for metronidazole, clindamycin and teicoplanin. The disc-diffusion method was used for the vancomycin susceptibility test. Three out of thirty-eight strains were resistant to vancomycin and twenty-eight were susceptible to teicoplanin. A widespread MIC was observed for clindamycin and metronidazole. No correlation between the origin of the strain, toxigenicity and susceptibility to teicoplanin, clindamycin, vancomycin and metronidazole was evident.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1828756

Source DB:  PubMed          Journal:  Cytobios        ISSN: 0011-4529


  6 in total

1.  In vitro activity of linezolid against Clostridium difficile.

Authors:  T Peláez; R Alonso; C Pérez; L Alcalá; O Cuevas; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole.

Authors:  T Peláez; L Alcalá; R Alonso; A Martín-López; V García-Arias; M Marín; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

3.  Antibodies to recombinant Clostridium difficile toxins A and B are an effective treatment and prevent relapse of C. difficile-associated disease in a hamster model of infection.

Authors:  J A Kink; J A Williams
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Authors:  T Peláez; L Alcalá; R Alonso; M Rodríguez-Créixems; J M García-Lechuz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

5.  Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions.

Authors:  V K Viswanathan; M J Mallozzi; Gayatri Vedantam
Journal:  Gut Microbes       Date:  2010-06-16

Review 6.  Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms.

Authors:  Saeed S Banawas
Journal:  Biomed Res Int       Date:  2018-02-21       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.